Bluebird Bio | Spese Di Vendita E Di Amministrazione

Selling And Administration Expenses Cambiamento Data
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
Avrobio USD 6.26M 1.68M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Moderna USD 470M 28M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Bluebird Bio Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.